Straumann Emdogain is an easy-to-apply, protein-based gel that is designed to promote predictable regeneration of lost periodontal hard and soft tissues caused by periodontitis, helping to save and preserve the tooth.1 Easy to apply with prefilled syringes, it is convenient to use and easily integrated into periodontal surgery.
*Based on units sold
**Compared to CTG
-Dr. David Cochran
Biological Guided Regeneration for Various Indications
Straumann Emdogain has documented clinical results in intrabony defects, recession defects, or furcation defects, either alone or with bone graft materials,** such as Straumann AlloGraft.
**Allograft, autograft, bone-derived xenograft, beta-TCP or bioactive glass.
1 Bosshardt DD. Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels. J Clin Periodontol. 2008 Sep;35(8 Suppl):87-105.
2 Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol. 2008 Sep;35(9):817-24. Epub 2008 Jul 21.
3 McGuire MK, Scheyer ET, Nunn M. Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue: comparison of clinical parameters at 10 years. J Periodontol. 2012;83:1353-1362.
4 Miller PD. A classification of marginal tissue recession. Int J Periodontol Rest Dent. 1985;5,8-135 Parashis, AO et al. Enamel Matrix Derivative in Intrabony Defects. Prognostic Parameters of Clinical and Radiographic Treatment Outcomes. J Periodontol 2012: epub ahead of print.
5 McGuire, MK & Nunn, M. Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue. Part 1: Comparison of clinical parameters. J Periodontol 2003;74:1110–1125
6 Jepsen S, Heinz B, Jepsen K, Arjomand M, Hoffmann T, Richter S, Reich E, Sculean A, Gonzales JR, Bödeker RH, Meyle J. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part I: Study design and results for primary outcomes. J Periodontol. 2004 Aug;75(8):1150-60.